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Open globe injuries are full-thickness injuries sustained to the eye wall (cornea or sclera), which cause immediate
drops in intraocular pressure that may lead to retinal detachment and permanent vision loss if not treated rapidly
after injury. The current standard of care for open globe injuries consists of suturing the margins closed, but the
technique can be time-consuming, requires specialized training and equipment, and can lead to patient discomfort,
abrasion, and infection from eye rubbing. We engineered an injectable, thermoresponsive sealant (TRS) and a
custom tool to occlude open globe injuries. The smart hydrogel sealant consists of physically cross-linked N-iso-
propylacrylamide copolymerized with butylacrylate. At low temperatures, it can be injected as a liquid, and when
raised to body temperature, a heat-induced gelation converts the hydrogel into a solidified occlusion. The sealant can
be repositioned or removedwithout causing additional trauma via exposure to cold water. In vitro and ex vivo assess-
ments of mechanical adhesion to eye tissue revealed maintenance of intraocular pressure that is five times greater
than the physiological range with reversible seal strength comparable to cyanoacrylate (super glue). In vivo assess-
ment in a rabbit model of ocular trauma demonstrated ease of use for TRS deployment, statistically significant im-
provement in wound sealing, and no evidence of neurotoxicity, retinal tissue degradation, or significant chronic
inflammatory response after 30 days of exposure. Given the advantages of body heat–induced gelation, rapid re-
versible occlusion, and in vivo safety and efficacy, shape-adaptable TRSs have translational potential as smart
wound sealants for temporary occlusion of surgical incisions or traumatic injuries.://st





At least 2.5million eye injuries occur in theUnited States each year, and
open globe injuries account for 10% of these injuries (1, 2). Open globe
injuries can quickly escalate in complexity and yield poor visual out-
comes if not managed carefully. Although incidence rates are relatively
low, virtually all open globe injury patients see a reduction in visual acu-
ity (VA), and the probability of VA loss increases with increasing time
to intervention beyond 24 hours from the injury (3). In addition to af-
fecting the quality of life of the patient, lifetime health care costs asso-
ciated with visual impairment can approach $500,000, thus also having
a major financial and societal impact (4).
Combat- and mass casualty–related ocular traumas are subsets of
ocular injuries in which time to intervention is often delayed due to cir-
cumstances where patients are separated from medical services or
triaged behind other casualties with more critical injuries. This delay
in receiving treatment increases the risk for substantial visual impair-
ment. In theU.S. campaigns in theMiddle East, up to 13%of all casualties
presented eye injuries, most attributed to improvised explosive devices
(5), and between 20 and 40% of battlefield ocular injuries included pen-
etrations to the sclera (6). A study of the Boston Marathon bombing
determined that 13% of those injured required ophthalmology inter-
vention (7). Military studies and clinical observations predict that treat-
ments closest to the time of injury have the best outcomes (8). In theseinstances, developing a strategy to rapidly and temporarily close the
globe without further trauma to the tissues is desirable.
Current treatment options formanaging open globe injuries include
sutures and adhesives. In general, these approaches require the use of
microsurgical instrumentation accompanied by surgicalmicroscopes to
visualize tissue repair. Foreign body sensation resulting from abrasive
material has been associated with eye rubbing, prolonged healing times,
infection, and fibrosis (9). Novel bioadhesives like fibrin matrices have
been used (9, 10) but can carry considerable risks associated with assur-
ancepreventionof viral or prion contamination, in addition to challenges
with glue deployment and ease of use. Cyanoacrylates (DERMABOND,
TRUFILL, and DYMAX 222) exhibit some difficulties in dispensing
and cannot be used to close globes with missing tissues (11). Acute in-
flammatory reactions in vascular tissue have been reported (12). There
are currently no U.S. Food and Drug Administration–approved indica-
tions for using medical adhesives for closure of scleral penetrations.
Here, we propose a system designed to temporarily occlude open
globe injuries. The system leverages the reversible, thermoresponsive
properties of poly(N-isopropylacrylamide) (PNIPAM) to reversibly oc-
clude injuries without causing additional trauma to surrounding tissues
during placement or removal. PNIPAM is a smart biostable polymer
investigated for a range of biomedical, drug screening, biotechnology,
andmedical diagnostics applications (13–16). Below about 32° to 33°C
[lower critical solution temperature (LCST)], hydrophilic interactions
of PNIPAM with water enable a translucent liquid state; above its
LCST, it forms a partially dehydrated, soft-solid aggregate. Through
copolymerization with other monomers, such as N-tert-butylacry-
lamide (NT) or butylacrylate (BA), we can tailor its thermoresponsive
behavior and mechanical strength to create a hydrogel that shape-fills
upon injection at a wound site, adapting to irregular margins and
sealing traumatic injuries. The thermosensitive behavior allows the
thermoresponsive sealant (TRS) to be easily removed by the application
of cold water.1 of 14
SC I ENCE TRANS LAT IONAL MED I C I N E | R E S EARCH ART I C L EWeused this copolymermaterial to develop a reversible approach to
temporarily occlude penetrating injuries to the posterior segment of
the eye. In addition to tailoring the polymer chemistry, we developed
a custom tool that controls the hydrogel temperature to enable effective
deployment in the eye. Feasibility studies were conducted using ex vivo
and in vivo models of ocular trauma in rabbits, and two user feedback
workshops were held wheremilitary ophthalmologists tested the proto-
type systems for ease of use, general concept, and performance in an ex










Engineered injectable TRS and mode of function
Our goal was to develop a biocompatible, tissue repair technology for
temporary intervention at sites of scleral tissue damage or loss. The ap-
proach presented here involves injection of a purposefully nonbiode-
gradable liquid sealant capable of body heat–induced gelation to create
a size-adaptable solidified occlusion, which can both restore intraocular
pressure (IOP) and be easily removed within a few days for subsequent
treatment without concomitant tissue damage. This technology would
afford the patient a larger windowof time to complete surgical interven-
tion without requiring specialty equipment such as surgical micro-
scopes for implementation. The system consists of two components:
(i) a thermoresponsive hydrogel that, by its reversible transition from
liquid to solid, conforms to wound shape and aggregates to mechani-
cally seal scleral penetrations and (ii) a custom deployment tool to con-
tain the hydrogel at a controlled temperature and to inject it at the
targeted site (Fig. 1A).
Optimizing rheological properties of shape-persistent,
moldable TRS
The physically cross-linked hydrogel with thermoresponsive behavior
was designed from customized copolymer and water. The reversible
transition fromwater-soluble coils to hydrophobic globules at the LCST
changes the physical properties of the gel (Fig. 1B). Copolymerization of
NIPAM with hydrophobic NT and BA not only decreases the LCST of
PNIPAMbut also improves the polymer’smechanical properties (17–20).
By altering the compositional ratios of these copolymers, a range of for-
mulations were synthesized via free radical polymerization and then
characterized to optimize molecular weight, LCST, aqueous solution
concentration, and viscoelastic properties (fig. S1). Previous studies
have used both comonomers to create cell culture supports and other
thermoresponsive polymers but not with synthetic uniformity or prop-
erties that met our needs (18, 20). As a result, we followed a different
synthetic scheme from those found in the literature and performed the
necessary measurement of LCST and molecular weight for all formula-
tions: homopolymers of NIPAM, copolymer of NIPAM with NT, and
copolymer of NIPAMwith BA, each using NIPAM as themain formu-
lation component (Fig. 1C). Composition ratios for each sample were
verified by 1H nuclear magnetic resonance (NMR) (fig. S2).
We deliberately engineered the LCST of the polymers studied here
to fall below that of PNIPAM to achieve a transition temperature for the
hydrogel that is well below the eye’s physiological temperature. The
contributions of the NT and BA monomers to the phase transition
were examined through scattering intensity measurements of aqueous
PNIPAM, poly(NIPAM-co-NT) (N85NT15), and poly(NIPAM-co-BA)
(N95BA5) solutions over temperature ranges that included their phase
transition temperature (fig. S3). Higher scattering intensity was ob-
served at higher temperatures (above phase transition temperature),Bayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017which was attributed to transformation from a more soluble coil con-
formation below the LCST to a largely insoluble compact conformation.
For instance, the scattering intensity values of N95BA5 exhibited sharp
increases around 16°C, indicative of a gelation point. Comparison of
temperature-dependent scattering intensity distributions of three differ-
ent hydrogels confirmed a PNIPAM gelation point around 32°C. By
inclusion of only 5% BA or 15% NT, the gelation points shifted to
16° and 22°C, respectively (Fig. 1D). We successfully engineered smart
hydrogels, N85NT15 and N95BA5, with appropriate transition tempera-
tures for human eye application.
The viscoelastic properties of the hydrogels were determined by rhe-
ological analysis. Conventional elastic responses at LCST were demon-
strated for both N95BA5 and N85NT15 samples (21). The loss (G″) and
storage (G′) moduli—representations of the viscous and elastic behav-
ior, respectively—were measured by strain amplitude sweeps across a
range of temperatures (figs. S4 and S5). Without a high-enough storage
modulus above LCST, the hydrogel would not be sufficiently elastic to
resist intraocular pressures while maintaining an effective occlusion.
Without an optimized loss modulus below LCST, the hydrogel might
be too runny or thick, making it difficult to apply. The storage modulus
for N95BA5 rapidly decreases above the critical strain region (1%), in-
dicating gel collapse to a quasi-liquid state (Fig. 2A). For different tem-
peratures, the respective G″ (6°, 24°, and 32°C) and G′ (24° and 32°C)
values of N95BA5 and N85NT15 were measured as a function of angular
frequency at fixed strain (0.1%) (Fig. 2, B and C). We observed that hy-
drogel dynamic moduli depend on the temperature and that both sam-
ples reached their maximum viscosity and elasticity at 32°C. Although
the mechanical strength of both hydrogels showed the same trend,
N95BA5 generated stronger polymeric networks. Replacement of NT
comonomerwith BA caused theG″ andG′ values to increase by a factor
of up to 30.
Comparison of the viscoelastic profile of 10% (w/w) aqueous solu-
tions of two different copolymers at eye temperature (32°C) differen-
tiated their aggregation behavior. G′ dominates over G″ for N95BA5,
resulting in a quasi-solid state (tan d ≡ G″/G′ ≈ 0.4). Under the same
condition, viscosity remained relatively greater than the elasticity for
N85NT15, indicating a quasi-liquid state (tan d ≡ G″/G′ ≈ 2.3) (Fig. 2,
D and E). N95BA5 was selected for further characterization, owing to its
mechanical strength and desirable phase transition temperature.
Viscositymeasurements of N95BA5 provided a better understanding
of the hydrogel’s conformational change (Fig. 2F). Below the gelation
point, complex viscosity, h*, was independent of temperature and con-
stant. At and above the phase transition region, the h* rose sharply and
approached a constant value. This change resulted from copolymer de-
hydration, compact globule formation, and resulting polymeric net-
works between macromolecule chains.
The complex viscosity profiles of N95BA5 solutions [5, 20, and
30% (w/w)] were then evaluated to compare their concentration-
dependent strength. Earlier gelation onset accompanied higher concen-
tration, indicating that more concentrated polymer solutions form gels
at respectively lower temperatures. The h* values also confirmed that
higher copolymer concentrations can improve the mechanical strength
of noncovalent hydrogels. Among the three samples studied, 30% (w/w)
had the greatest complex viscosity value of about 10,000 centipoise (cP)
(10 Pa · s), suggesting a strong yet injectable thermoresponsive hydrogel
(fig. S6). For comparison, the viscosities of honey and ketchup, two eas-
ily applied yet malleable substances, are about 3000 and 50,000 cP, re-
spectively. The 30% (w/w) N95BA5 was chosen for having the most
useful viscoelastic properties of the hydrogels prepared herein (Fig. 1C).2 of 14
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The stiffness and resilience of the 30% (w/w)N95BA5were evaluated
using standard tensile and compression tests and by casting it into
shapes. Compressive stress-strain curves illustrated a positive correla-
tion between TRS concentration and compressive moduli. The results
revealed that the mechanical properties of the developed hydrogel can
be readily tuned by changing the hydrogel concentration, with com-
pressive moduli modified from less than 15 to≈55 kPa when doubling
the TRS concentration from 15 to 30% (fig. S7). The elastic modulus of
N95BA5 was characterized as a function of the concentration (20, 25,
and 30%). TRS tensile stress-strain curves followed a similar trend,Bayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017with increasing copolymer concentration resulting in higher Young’s
modulus. The 30% TRS hydrogels were found to have elastic moduli
of 117 kPa, representing an improved stretching capacity compared
to 60 kPa (25%) and 45 kPa (20%) (fig. S8). The resultingmolded objects
(Fig. 2, G to I) were resilient and sufficiently cohesive at body tempera-
ture to be suspended horizontally (Fig. 2J), vertically (Fig. 2K), and by
hand (Fig. 2L). The noncovalent properties of the hydrogel also allowed
it to self-heal when slightly deformed. The hydrogel satisfied critical re-
quirements for application as an ocular sealant: moldability, persistence
in form, and sufficient toughness to withstand intraocular pressure.Fig. 1. Design of a thermoresponsive hydrogel to seal scleral perforation.
(A) Schematic depicting implementation of a temperature-mediated adhe-
sive hydrogel that adapts to wound shape and a tool for its deployment at a
perforation site in the sclera. (B) Images of the changes in physical proper-
ties as the sealing hydrogel transitions from hydrophilic coils to hydropho-
bic globules at its lower critical solution temperature (LCST). (C) Molecular
structures of formulations of poly(N-isopropylacrylamide) (PNIPAM) with
butylacrylate (BA) or N-tert-butylacrylamide (NT) and a table of resulting al-
terations of molecular properties and LCST values. (D) Normalized scatter-
ing intensity as a function of temperature for PNIPAM, poly(NIPAM-co-NT) (N85NT15), and poly(NIPAM-co-BA) (N95BA5). A.U., arbitrary units.3 of 14
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Ex vivo and in vitro testing of N95BA5 for ocular trauma
Sealant efficacy of the hydrogel was first assessed in an ex vivo cadaveric
porcine eye model of ocular trauma. Cyanoacrylate was selected over
fibrin-, albumin-, and polyethylene glycol–based adhesives as a positive
control because of its well-documented superiority in maintaining IOP
and uniaxial adhesion strength (22, 23). The hydrogel was applied to the
lacerated eye model after an incision procedure (Fig. 3A). The hydrogel
was injected into the posterior chamber of the eye through the perforation,
and the injection tool was slowly retracted while continuously deploying
the hydrogel, leaving a sealant trail through the wound. At the exteriorBayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017surface of the sclera, additional hydrogel was deposited, creating a gel rivet-
like cap. The caps were left to settle for several seconds, allowing them to
increase in temperature and dehydrate before being cut away or smoothed
flat (Fig. 3, B and C). IOP was then controllably raised by infusion with
warm saline from the cannula inserted in the posterior chamber.
By comparing the IOP values established at eye temperature (32°C)
by 15, 20, and 30% (w/w) aqueous solutions of N95BA5 and N85NT15,
N95BA5was determined to be the superior hydrogel,maintaining ocular
pressures above 70 mmHg for all concentrations. Under the same
conditions, IOP values for 15 and 20% N85NT15 were less effective,Fig. 2. Rheological characterization and hydrogel differentiation. (A) Storage and lossmoduli (G′ andG″, respectively) over strain for N95BA5. (B and C)G″ (B) andG′ (C)
modulus representations of viscoelastic behavior for co-BA and co-NT as a function of angular frequency at fixed strain. (D) Table of storagemoduli for co-NT and co-BA
compositions at different angular frequencies. (E) Storage and loss moduli (G′ and G″, respectively) over frequency for co-NT and co-BA compositions. (F) Measurement
of complex viscosity for N95BA5 according to temperature. (G to I) Images of square and round gelmolds formed by heating the hydrogel solutions to 32°C. Scale bars, 1 cm.
(J to L) Images of solid N95BA5 hydrogel demonstrating horizontal resilience (J), vertical resilience (K), and strength of form on contact (L). Scale bars, 1 cm.4 of 14
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containing pressures of 5 and 40 mmHg, respectively (Fig. 3D). Al-
though high concentrations (30%) of bothN95BA5 andN85NT15 hydro-
gels were capable ofmaintaining pressures of up to 72mmHg, leakage
was observed for N85NT15, indicating a quasi-sealed state. Even so,
the formulations identified as effective could withstand IOPs of up to
77mmHgwithout leakage, an environment approximately five times the
physiological IOP range. Both theN95BA5 samples and a cyanoacrylate-
sealed positive control held the maximum pressure (78 mmHg) of ourBayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017experimental setup, demonstrating effec-
tive equivalence. In contrast, our negative
control without a sealant held no pres-
sure. Figure 3E shows a hydrogel plug re-
moved from one of the rabbits at the end
of the study.
Although we designed the hydrogel as
an ideal mechanical sealant, in vitro uni-
axial adhesion tests were performed to
provide accurate comparison between the
adhesion force of cyanoacrylate, the stron-
gest ocular adhesive, and our TRS. The
hydrogel or cyanoacrylatewas sandwiched
between two pieces of dissected scleral
tissue that were fixated to the base and ac-
tuator arm of a pull tester (Fig. 3F). Ap-
posed tissues were brought down and
pressed together using 15g of pressure
for 2 min. The actuator was then pulled
until the two tissue samples detached. In
addition to the 30% N95BA5, different
aqueous concentrations of PNIPAMrang-
ing from 0.8 to 43% (w/w) were chosen to
assess the impact of concentration. Adhe-
sion results of homopolymers suggested
that an increase in the aqueous concentra-
tion of the hydrogel increased the adhe-
sive strength between the hydrogel and
scleral tissue. Adhesion forces between
336 and 560 mN were observed for the
30% (w/w) N95BA5 before adhesion fail-
ure at the tissue-hydrogel interface.Under
the same uniaxial conditions, cyanoacry-
late’s adhesion force was slightly higher
(Fig. 3G). Wetting, diffusion, and adsorp-
tion theories offer mechanical andmolec-
ular explanations for this behavior but
were not explored in this study (24, 25).
In situ gelation mechanism of TRS
in the eye
Ex vivo application indicated that to oc-
clude the incision properly, the hydrogel
must change from transparent liquid to
white solid (Fig. 3B). We used dynamic
light scattering (DLS) techniques to obtain
particle size in solution, gel and solution-
to-gel transition states, and particle im-
pact on gelation kinetic and mechanical
properties. At 2°C, below LCST, we ob-
served that 96% of the intensity corre-sponds to particles with a small hydrodynamic radius (3.6 nm),
attributed to single polymer chains in the coil conformation (Fig. 4A).
At the phase transition region, we observed two peaks with compa-
rable intensities. One peak (236.2 nm) corresponded to N95BA5 mole-
cules thatwere partially aggregated in the solution, and the other peak
(4.5 nm) corresponded to lower-radius particles (Fig. 4B). Further tem-
perature increase to 20°C caused 98% of the copolymer to form large ag-
gregates (439 nm), a consequence of more favorable polymer-polymerFig. 3. Preliminary ex vivo and in vitro hydrogel evaluation. (A) Schematic (top) and image (bottom) depicting
ex vivo procedures carried out in a pressure-controlled explanted cadaveric pig eye. (B and C) Images (B) and schematic
depiction (C) of hydrogel injection through scleral perforation by deployment of a sealant trail through the wound,
leaving rivet-like caps subsequently removed to leave the occlusion flush with the scleral surface. (D) Comparison of
maintained intraocular pressures across a concentration spectrum for N95BA5 and N85NT15 hydrogels (n = 3 per group).
(E) Image of a solid plug removed from a test eye. (F) Schematic depicting tissue adhesion tests comparing PNIPAM,
N95BA5, and cyanoacrylate adhesion strength to scleral tissue ex vivo. (G) Adhesion force of different concentrations of
N95BA5, PNIPAM, and cyanoacrylate to scleral tissue; columns show 478 ± 71 and 639 ± 110 for N95BA5 and cyano-
acrylate, respectively (n = 3 per group).5 of 14
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interactions (Fig. 4C). Amide groups facilitated those interactions by
forming hydrogen bonds between polymermolecules, nesting themselves
inside the globules.
Intensity distribution across a range of temperatures (2° to 20°C)
allowed further characterization of the temperature-induced hydropho-
bic aggregation process (fig. S9). For brevity, the size distribution graphs
of only four temperatures (2°, 8°, 12°, and 20°C) were included (Fig. 4D).
With temperature increase, the first peak corresponding to smaller parti-
cles decreased in size. Simultaneously, hydrodynamic radius (RH) and in-
tensity of the high aggregation peak region increased with heat (Fig. 4D).
Analysis of RH values for N95BA5 aggregates provided detailed
understanding of the gel’s temperature dependence. At temperatures
below the LCST, RH remained nearly constant (<10 nm) up to 10°C,
but increasing the temperature above the 12°C gelation onset condition
led to a rapid increase in the hydrodynamic radius and to sizesmarkedly
larger than the PNIPAM aggregates (26). Greater aggregate size makes
for better ocular sealant because larger particles diffuse less readily into
the vitreous gel, as predicted by the Stokes-Einstein equation. The ag-Bayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017gregation onset temperature was confirmed by the results of scattering
intensity tests. DLS measurements could not be performed above 20°C
because of the turbidity gain of the hydrogel solution (Fig. 4,E and F). In
summary, the nanometric copolymer aggregates associate upon expo-
sure to heat, becoming insoluble in aqueous solution as a consequence
of more favorable polymer-polymer interactions.
As observed previously, heated hydrogel can form shape-persistent
objects by in situ gelation. The thermo-induced volume change of these
molded shapes was further characterized to investigate hydrogel stabil-
ity in an environment similar to the eye. The swollen hydrogel under-
went slight volume reduction after only 5 min of exposure to 32°C
deionized water. Shape persistence and stability remained for 1 month
in an aqueous environment above its LCST (Fig. 4G). These formed
shapeswere alsomaintained at 10°C, belowLCST, resulting in complete
structural collapse after a few hours, consistent with the thermorespon-
sive trends observed (fig. S10).Ourhydrogel challenges the preconception
thatmaterials held together by noncovalent forces andmostly composed
of water are weak.Fig. 4. Hydrogel particle size and gelation mechanism. (A) N95BA5 particle size as assessed using dynamic light scattering in solution below LCST (2°C), showing a
96% scattering intensity for small-radius particles. (B) Particle size in the phase transition region (12°C). A split was observed between particles with hydrodynamic radius of
4.5 and 236.2 nm. (C) Particle size toward the end of the phase transition region (18°C). Ninety-eight percent of scattering intensity was due to large-radius N95BA5
aggregates. (D to F) Hydrodynamic radius size of particles traced through the hydrogel transition to show higher aggregate populations at higher temperatures (n = 3 per
temperature). (G) Gross images of molded hydrogel samples held at the expected eye temperature (32°C) for up to 30 days, showing slight volume decrease and good
shape persistence and stability.6 of 14
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of ocular trauma
Effective deployment of the hydrogel without premature transition re-
quired development of a controlled-environment injector tool to meet
optimal use requirements derived from clinical end users (table S1). The
preliminary design consisted of a 1-cm3 chamber inside a larger 15-cm3
thermal jacket (Fig. 5A, a) in an easily used form factor. On the basis of
the preliminary design and volume of space available inside the thermalBayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017jacket, a series of endothermic chemical reactions of ammonium nitrate
salt and water was performed and optimized to rapidly cool the hydro-
gel chamber to 0°Cwithin 60 s ofmixing and tomaintain the hydrogel’s
temperature between 0° and 10°C for up to 10 min (Fig. 5A, b). A
working prototype was fabricated from off-the-shelf parts, including a
1-cm3 syringe nested inside a larger 15-cm3 syringe and a soft remov-
able loading port cap, which allowed ammonium nitrate to be loaded









Fig. 5. Preliminary performance validation of the hydrogel in vivo in a rabbit model of scleral trauma. (A) Design diagrams (a and c) and validation (b) of a custom
injection tool to effectively control hydrogel deployment and regulate its temperature. An image of the prototype injector is shown in the bottom right. (B) Two-arm study
design to assess safety and efficacy of the hydrogel versus the current standardof care for posterior segment openglobe injuries. (C) Images of the surgical procedure in rabbits.
A 3-mm, full-thickness linear incision was created in the sclera about 3 mm radial from the limbus, followed by preparation and deployment of the hydrogel through the
incision. (D) Representative baseline intraocular pressure (IOP) values showing no statistical difference between eyes of the same animal or any circadian-induced variations;
columns show 6.5 ± 0.2, 6.5 ± 0.2, 5.8 ± 0.2, 6.4 ± 0.3, 8.1 ± 0.4, 8.0 ± 0.4, 7.4 ± 0.5, and 8.6 ± 0.4 mmHg (n = 28 per group). (E) Wald test comparison of mean IOP values of the
treatment group versus no intervention, after procedure, showed a statistically significant improvement in mean IOP with sealant placed (*P < 0.05 and **P < 0.001).7 of 14
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use (Fig. 5A, c). Cooling characteristics were optimized by varying
reactant concentrations and tracking temperature transients to
achieve the desired deployment window (fig. S11). A polymer-based
catheter cannula was also used on the injector tip for hydrogel ap-
plication to reduce thermal conductivity from the eye, which could have
induced temperature transition solidification in the tool’s lumen during
deployment.
An in vivo pilot validation study was performed in a rabbit model of
ocular trauma to assess the ease of use, safety profile, and preliminary
efficacy of the N95BA5 hydrogel. A 7-day in vivo follow-up study was
performed to compare the performance of the hydrogel wound closure
versus no intervention (control). A subset of the study animals were
followed for an additional 3 weeks (4-week endpoint) to more carefully
examine safety and potential inflammatory responses to hydrogel place-
ment in the eye (Fig. 5B and table S2).
For each test run, a 3-mm full-thickness lacerationwas created in the
sclera to simulate a penetrating injury (Fig. 5C, a). After trauma creation
in a treatment group rabbit, the tool was inserted into the laceration
(Fig. 5C, b) and the hydrogel was deployed (Fig. 5C, c). Once deployed,
the hydrogelwas then allowed to set for 5min, enabling the dehydration
transition from translucent (Fig. 5C, c and d) to an opaque white color
(Fig. 5C, e). Expelled water formed visible droplets on the gel surface
(Fig. 5C, f). The rivet cap formed on the ocular surface was then cut
away to create a low-profile, flat head (Fig. 5C, g to i). The procedure
can be viewed in movie S1. Ease of use of deployment was evaluated by
comparing the number of successful hydrogel placements into the eye
versus the number of hydrogel placement attempts.
Despite limited training with the system, the veterinary surgeon was
able to successfully deploy the hydrogel on the first attempt in greater
than 80% of the cases (table S2). During follow-up, trauma sites in the
control group were difficult to locate. The conjunctival epithelium
formed a fibrotic layer across the margins in an attempt to repair the
breach. Although suggestive of a natural healing process, the eyes still
exhibited hypotony with IOPs of ≤4 mmHg, likely attributable to a
leaky, porous closure.
The scleral surface of all study eyes [right eye (OD)] was visually
evaluated by an ophthalmologist at 24 hours, 48 hours, and 1 week to
look for signs of scleritis or other vasculitis of surrounding tissues that
might be indicative of adverse tissue responses to the hydrogel material
(fig. S12). Despite some signs of acute inflammation in the first hours
(less than 12 hours) after the original procedure, irritation rapidly sub-
sided. By the 24-hour mark, treatment and control eyes were barely
distinguishable. Evaluation at 48 hours after surgery revealed no hyper-
emia or inflammation at the treatment site, which persisted until study
termination.
Hydrogel efficacy in situ was evidenced by IOP restoration to nor-
mal ranges and negative Seidel test, the standard clinical test for identi-
fying ocular leakage/dehiscence. Mean baseline IOP values showed no
statistically significant difference between the study eye (OD) and fellow
eye (OS) of each animal (presurgical OD/OS between groups, P = 0.35),
consistent with previous reports (Fig. 5D) (27). Immediately after inci-
sion creation, both treatment and control groups showed significant de-
creases (>80%) in mean-normalized IOP. As restoration of IOP relied
on physiological production of aqueous humor, immediate improve-
ment in IOP was not expected in both groups.
A noticeable IOP increase occurred about 12 to 24 hours after
procedure in the treatment group, and statistically significant improve-
ment in IOP continued over the 72 hours after placement of the hydrogel
relative to the control (Fig. 5E and table S3). Normalizedmean IOPmea-Bayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017surements across all time points beyond 24 hours after procedure
showed statistically significant improvement over control, with an even
greater improvement noted beyond 48 hours (P < 0.05). Normalized
to the mean normal clinical IOP (15.5 mmHg), the lower threshold
for normal human IOP pressure (10 mmHg) becomes 65% (28), and
unrepaired globesmaintained a low IOPno greater than 30%of normal.
In stark contrast, hydrogel closure consequently raised IOP to 90% of
the minimum threshold for normal IOP and sustained IOPs almost
twice the magnitude of no treatment.
N95BA5 biocompatibility up to 1 month after
ocular implantation
Histological analysis was performed at 48 hours, 1 week, and 4 weeks
after hydrogel implantation to investigate potential adverse reactions.
Tissue cross sections with the laceration and hydrogel placement sites
marked (Fig. 6A, black arrows) show the trauma site and hydrogel
placement location. A comprehensive analysis of tissue reaction over
intervention time course was drafted by a certified pathologist (table
S4). Despite design intent for acute intervention, elongated exposure
allowed inspection of chronic inflammatory reactions, usually observed
at 3 to 4 weeks after an implantation (29).
At 48 hours, control group wound margins appeared clean with the
presence of some acute inflammatory cells (Fig. 6A, top left). Partial
evulsion of peripheral retina was noted at the margins (blue arrow) of
the control group along with some inward epithelial migration (red
arrow). At 1 week, the control eyes exhibited a typical acute inflamma-
tory response, forming a porous fibrotic layer bridging the lesion mar-
gins that matured from a positive Seidel test (confirmed leakage) to a
complete IOP-supportive barrier by week 4. At week 1, there was no
evidence of inflammation or infection in scleral tissues, but epithelial
migration into the posterior chamber was observed. Trichrome staining
revealed the mature (week 4) barrier to be dense and primarily com-
posed of collagen fibers, a natural healing response. Small distributions
of inflammatory markers were found in the newly formed tissues, but
there was no evidence of chronic inflammation.
Treatment group eyes exhibited similar clean laceration margins at
48 hours with some retinal tissue evulsion; however, the opposing
margins were noticeably separated (Fig. 6A, right) as a result of the hy-
drogel occlusion. Acute inflammatory cells at woundmargins and slight
inward epithelial layer migration were consistent with acute traumatic
injury. An immature encapsulation layer formed over the wound by
week 1, with no evidence of lesion closure or epithelial bridging, provid-
ing a quantitative metric for the foreign body reaction (Fig. 6B). The
layer had a moderate thickness (51.0 ± 15.7 mm) of 10 to 20 cell layers.
At 4 weeks, the encapsulation matured into a compact (13.4 ± 4.9 mm)
tissue layer lining the margins of the lesion. Trichrome staining con-
firmed this layer to be rich in collagen, indicating evidence of a mature
and compact fistula with a minimally adverse tissue response and no
evidence of chronic inflammation forming around the hydrogel plug.
The sclera also created an immature encapsulation layer containing
some inflammatory cells, which separated the scleral tissue from the
implant. Despite small quantities of infiltrate observed in the scleral
margins at week 1, there was no evidence of sustained or excessive in-
filtrate, giant cell formation, or other chronic inflammation indicators
at week 4.
Treatment group retinas showed no evidence of detachment and
showed no evidence of neurotoxicity after 4 weeks of exposure (Fig.
6C). Different approaches have been used previously to assess neuro-
toxicity, including neurophysiological electroretinogram recordings8 of 14
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and histological study of retinal structure (30). Treatment group physical
retinal evaluation showed no signs of photoreceptor outer segment de-
generation or other evidence of disorganization in the laminar tissue
structure (Fig. 6C, bottom row). Organized ganglion cell layers, inner
and outer plexiform layers, and nuclear layers were also present, along
with retinal photoreceptor outer segments, all consistent with normally
functioning retina. Any separation between the retina and choroidal
layers was confirmed as artifacts of the histological slide preparation,Bayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017which is a common observation (31).
Even 30 days after implantation, the treat-
ment group retinal tissues showed no
signs of degradation or detachment.
User feedback workshop with
military ophthalmologists
and technicians
To validate the potential implementation
of this technology in the clinic, two user
feedback workshops were organized to al-
lowmilitary clinical personnel, whomight
see ocular trauma casualties, to use the
TRS system in a benchtop model of rup-
tured globe injury (fig. S13). Two user
feedback workshops that collectively
captured end user feedback from 53 clini-
cians (ophthalmologists, physicians,medics/
technicians, and researchers) with experi-
ence or career interests in managing oc-
ular trauma in combat casualties were
organized. The objective of these exercises
was to assess the clinical relevance of the
technology design and to capture any ad-
ditional design refinements.
Each participant was given a brief tu-
torial and then asked to treat an enucleated
pig eye with a full-thickness scleral lacer-
ation (0.5 to 2.0 cm in length). Each par-
ticipant was given two attempts to close
the globe. After sealant placement, warm
saline was infused into the eye via a can-
nula to test integrity. Forty-three percent
of the participants were able to success-
fully deploy the hydrogel at the site to ef-
fectively occlude the ruptured globe on
the first attempt. All of the participants
(100%) were able to successfully deploy
the hydrogel at the site of the injury and
close the globe in two attempts.
A questionnaire was administered to
the participants with write-in (table S5)
and multiple choice (table S6) questions.
Of the responses collected, 69% of the re-
spondents (n = 22) thought the idea of the
reversible occlusion for open globes was a
good idea (table S5), with 59% thinking it
was great. Thirty-one percent found the
system easy to use, with 25% noting that
the system required minimal training.
Perhaps most interesting, 94% of the re-sponders (n = 30) said that they could envision the system being used
in the field or in managing combat casualties.DISCUSSION
PNIPAM and its copolymers have been extensively explored, but the
combination of NIPAM and BA to target a biologically relevant tran-
sition temperature andmechanical properties pursues a unique trajectory.Fig. 6. N95BA5 biocompatibility beyond intended use frame. (A) Series of histological cross sections prepared for
control (left pairs) and treatment (right pairs) in hematoxylin and eosin (H&E) andMasson’s trichrome stain for each of
the study endpoints (t = 48 hours, 1 week, and 4 week). Scale bars, 800 mm. (B) Increased magnification of one of the
laceration margins for the treatment group showing evolution of the tissue-hydrogel interface from acute inflamma-
tory infiltrate to a mature, compact fibrotic encapsulation layer at 4 weeks. Scale bars, 50 mm. (C) Gross visualization
(top row) and high-magnification (bottom row) evaluation of treatment group retinas showing no evidence of trauma-
induced retinal detachment or hydrogel-induced retinal neurotoxicity. Scale bars, 5 mm (top row) and 100 mm
(bottom row).9 of 14
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Previous studies have imbued custom copolymers with the temperature
sensitivity of PNIPAM, achieving pH-resistant graft copolymers, altered
LCSTs, and temperature-dependent drug diffusion (13, 32). Responsive
properties of PNIPAM have also been applied to acylated polymer-
bound parylene C for temperature-mediated tissue binding (33). With
these dynamic modifications in mind, PNIPAM was an obvious foun-
dation for an impermanent, biological sealant. To be used in the eye at
32°C, however, the LCST needed to be lowered.
Selection of the ideal copolymer conformation required examination
of temperature-dependent aggregation behavior. Previous studies of
PNIPAM copolymer behavior have used viscosity and DLS measure-
ments to characterize particle size and shape (34). Our findings verified
the concentration-dependent properties of hydrogel aggregation for this
engineered conformation—higher concentration slightly lowered LCST
—and reaffirmed non-Newtonian characteristics observed in studies of
additive effects (35, 36). The quasi-solid state of the 30%N95BA5 hydro-
gel, in conjunction with its lowered LCST, distinguished it as the ideal
candidate. Potential further improvements to the aggregation process
could be explored via the heating protocol as a sample’s temperature
history can affect rheological properties (37).
Successful completion of the hydrogel design and characterization
enabled advancement to preliminary ex vivo and in vitro performance
and safety assessments. Hydrogel plugs maintained IOPs greater than
normal physiological IOP, suggesting the possibility of prolonging the
injury-to-operation window, but doing so with a reversible sealant. In
addition, the non-Newtonian state of N95BA5 allowed it to adapt to
wound irregularities and also exhibit self-healing characteristics. This
resilience has been noted in other noncovalent hydrogels, supporting
the idea that these moldable materials can exhibit significant mechanical
strength (21). In contrast, the NT comonomer proved less effective at
maintaining high IOPs in the ex vivo test protocol, a result that paralleled
reports of n-butyl cyanoacrylate scleral sealants preventing high IOP
leaks in similar models (38).
The in vivo study provided preliminary insight into the hydrogel’s
efficacy in occluding open globe injuries. Whereas control groups ap-
proached 30%of normal pressure, treatment group IOP reached as high
as 60%, which was corroborated by negative Seidel tests. The hydrogel
formed a barrier capable of improving IOP during a 72-hour wait time
for treatment.
Our preliminary biocompatibility assessment of N95BA5 suggests no
significant adverse effects. Most reported studies on PNIPAM bio-
compatibility for biomedical and cosmetic applications support our
findings (39–42); however, there has been one report of some observed
tissue inflammation (43) and another reporting IOP decrease (44). No
suchhistory of testing exists for the hydrogel studied here, but PINIPAM
copolymerized with BA has demonstrated basic cell compatibility (45).
Our examinations demonstrated no neurotoxicity, no retinal tissue deg-
radation, and no significant chronic inflammatory response after sus-
tained exposure (30 days). Study limitations have now been addressed
in this paragraph, and after an exhaustive literature review, we are not
aware of any further material limitations. This preliminary demonstra-
tion of safety still requires a larger study size to rule out effects on retinal
function.
Clinical user feedback is a valuable element in developing new inter-
ventions and therapies, and here, we specifically targeted military clini-
cians, who have encountered or who will encounter ocular trauma
under conditions where temporary interventionmay be preferable over
full intervention. Although full intervention at first admission is pre-
ferred (8), some scenarios, such as mass casualty events, may createBayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017scenarioswheremultiple ocular injuriesmay delay intervention (7). The
feedback captured from the military clinicians provided some good
validation that the ease of use and the relevance of the technologywere
both real.
This study establishes foundational feasibility, safety, and efficacy of
N95BA5 as a reversible thermoresponsive hydrogel for temporary
closure of scleral perforations. This tissue repair technology sustained
IOPs five times greater than the physiological range in bench testing
of maximum adhesion, prevented hypotony for 72 hours after scleral
trauma, and demonstrated sufficient biocompatibility for exposures
longer than the intended use period. Furthermore, the hydrogel’s adapt-
ability to wound shape and unique deployment methodmake a unique
and easy alternative to conventional methods.MATERIALS AND METHODS
Study design
The overall objective of this study was to assess the feasibility of devel-
oping a temporary ocular repair technology with physical andmechan-
ical properties suited to improving outcomes for globes compromised
by scleral tears. This objective was segmented into three efforts: a poly-
mer chemistry investigation of hydrogel properties correlated to syn-
thesis route and composition, a materials science study of performance
characteristics using benchtop models of ocular trauma, and an in vivo,
preclinical study of safety andperformance in an animalmodel of ocular
trauma. Our initial work evaluated the potential of two compositions
at different concentrations. These copolymers incorporated hydropho-
bic monomers (NT and BA) with NIPAM to form a temperature-
responsive hydrogel in water with improved mechanical strength.
Preliminary evaluation consisted of transition temperature’s shift veri-
fication by scattering intensity, followed by examination of storage and
loss moduli for relative viscoelastic properties. Identification of N95BA5
as the preferred sealant was followed by compression, tension analysis, and
tissue adhesion tests at eye temperature. Secondary evaluation consisted of
in vitro and ex vivo testing of different concentrations of the N95BA5
hydrogel in appropriate porcine test models. These tests led to further
narrowing of the potential candidate compositions to only the 30% (w/w)
N95BA5 for advancement to in vivo performance and safety testing.
The sealant technology safety and performance were assessed in
an in vivomodel of ocular trauma. A 2:1 (treatment/control) randomized
and unblinded study was designed to evaluate the hydrogel sealant
against the envisioned standard of care (no intervention). All animals
(n = 18) received a 3-mm full-thickness laceration through the sclera,
and treatment arm animals (n = 12) received the hydrogel sealant. All
animals had regular IOP measures taken in triplicate at each time
point to calculate a mean IOP for each time point. Animals were
followed to one of three study endpoints (48 hours, 1 week, and 4
weeks), after which eyes were enucleated and fixed for histological
preparation and analysis. Tissue segments were examined for evidence
of adverse tissue responses including chronic inflammation, retinal
degradation, cytotoxicity, and neurotoxicity.
Homopolymer and copolymer synthesis
PNIPAM, copolymer of NIPAM andNT (N85NT15), and copolymer of
NIPAM and BA (N95BA5) were synthesized using free radical polymer-
ization (44, 45). ForN85NT15, a solutionofNIPAM(4.25 g),NT (0.75 g),
and 2,2′-azobisisobutyronitrile (0.021 g) was dissolved in 60 ml of dry
tetrahydrofuran (THF). Themagnetically stirred solutionwas degassed,
heated to 50°C for 24 hours under positive nitrogen pressure, and10 of 14
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allowed to cool. The reaction mixture was filtered (0.45-mm Teflon fil-
ter), and the filtrated volumewas reduced by half. Ether was added with
mixing to precipitate the copolymer. The precipitate was filtered off,
washed with ether, and dried under vacuum to yield dry 4.64 g of co-
polymer product. For N95BA5, we followed the same procedure except
that we used a different ratio of NIPAM (4.75 g) to BA (0.25 g). Using
different ratios of THF/benzene as a solvent, we were able to synthesize
homopolymers and copolymers with various molecular weights and
polydispersities. After differentiation of the hydrogel compositions and
the identification of N95BA5 for further application, the copolymer was
then purchased from Sigma-Aldrich.
1H NMR
Feed ratio accuracy was confirmed by 1H NMR (Varian VNMRS-600).
We prepared 5% (w/w) solutions of N85NT15 and N95BA5 in CDCL3.
Peak integration ratios were compared to theoretical ratios for compo-
sitional verification.
Hydrogel solution preparation
The required amount of PNIPAM, N85NT15, and N95BA5 was weighed
for various concentrations of hydrogel aqueous solutions, from 0.8 to
43.2% (w/w). The powder was added directly to the sterile water. The
vial containing the polymer suspension was then processed with a
Misonix Sonicator 3000 using a cup horn high-intensity ultrasonic wa-
ter bath at the maximum power setting (10) due to sample viscosity. A
circulating temperature control water bath held at 2°C prevented sam-
ple heating due to prolonged horn activity. The sample was sonicated
until a transparent clear hydrogel was obtained. The required sonication
time ranged from 1 to 30 hours and depended on the hydrogel concen-
tration and molecular weight of the homopolymers/copolymers.
Scattering intensity analysis
Scattering intensity measurements of 5% (w/w) hydrogels were carried
out using a Photon Technology International Quantamaster fluores-
cence spectrophotometer. All intensity measurements were performed
at an excitation wavelength (lex) of 450 nm, with detectors positioned
90° from the light source. Emission spectra were recorded with a slit
width of 0.1/0.1 nm. Quartz cuvettes (1 cm × 1 cm × 3 cm) containing
the sample were placed in a cell holder, which was electrothermally
controlled at a precise temperature regulated by a Peltier cooler. Each
hydrogel was left under undisturbed conditions for 20min at each tem-
perature to obtain thermodynamic equilibrium.
Because the input light source was directed at the sample, the parti-
cles redirect the light away from a direct course through the cuvette with
increasing severity as particle size increases. For small particle sizes,
most of the input beam traverses the sample directly, resulting in small
scattering measurements. As particle size increases, more of the light
affects the particles, resulting in sideways diffusion of light that could
be focused and then received by the sensor at 90° to the input beam.
Scattering values were then normalized. Because of increase in sample
opacity above LCST, most of the input beam was eventually reflected
upon initial contact with the sample. As a result, higher temperatures
saw a slow decrease in intensity because less input beam reached the
center of the sample to be scattered toward the receiver.
Rheological analysis
AnAnton PaarModular Compact Rheometer (MCR)was used tomea-
sure the rheological properties of hydrogels. Eightmilliliters of 10% (w/w)
N95BA5 and N85NT15 hydrogel solutions was placed into the cylinderBayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017with special care to avoid evaporation of water. First, the hydrogels were
investigated with strain-amplitude sweeps below their LCST (6°C), at
LCST, and above the transition temperature (32°C) at constant angular
frequency (10 rad s−1). After the critical strain was found for each hydro-
gel, oscillation testswere performed tomeasure the loss (G″) and storage
(G′) moduli at a designated temperature (6°, 24°, and 32°C) using a cir-
culating temperature control water bath. Strain was fixed at 0.1% (below
the critical strain), and moduli were measured as a response to logarith-
mic angular frequency ramp from 0.1 to 1000 rad s−1. Temperature-
dependent changes in complex viscosity were performed using a fixed
angular frequency of 10 rad s−1, 0.1% strain, and a heat rate of 0.5°C/
min on 5, 10, 20, and 30% (w/w) N95BA5 samples.
Compression test
To perform compression testing, liquid hydrogels were injected into a
17-mm × 17-mm × 5-mm glass mold and then heated to 32°C using a
temperature-controlled Instron 5567 mechanical tester. After a 2-min
curing period, the glassmold was removed, and the probe was placed in
contact with the top of the molded hydrogel. The samples were then
compressed at a rate of 1 mm/min. A stress-strain curve was obtained,
and compressive modulus was determined as the slope of the linear
region corresponding to 5 to 15% strain. The number of hydrogel
samples was three per group.
Tensile test
Liquid hydrogel samples were shifted to the solid phase (32°C) using a
hot plate and were detached from a metal mold. Samples were then
blotted dry and fixed by two clamps of an Instron 5942 mechanical tes-
ter. The solid samples were stretched at a constant rate of 1 mm/min
under controlled temperature. Young’s modulus was determined as the
slope of the linear region of the stress-strain corresponding to 0 to 10%
strain.
Hydrodynamic light scattering analysis
Intensity distribution and RH of 5% (w/w) N95BA5 aggregates were
measured by the automated DynaPro Plate Reader II (Wyatt Technol-
ogy). TheDLS equipment is equippedwith a thermostat-equipped sam-
ple chamber to maintain desired temperatures within a range of 4° to
85°C with great accuracy. A bubble-free sample of about 80 ml was in-
troduced in a square glass cuvette through a micropipette. A drop of
mineral oil (20 ml) was placed on the top sample solution to prevent
water evaporation. Then, the sample cell was placed in the sample
chamber of the DLS instrument and kept at constant temperature for
30 min, a procedure repeated for all desired temperatures to ensure
thermodynamic equilibrium. This instrument measures the movement
of particles under Brownian motion and converts this motion into size
by using the Stokes-Einstein equation, as given below,
D ¼ kT=6phRH
where k is the Boltzmann’s constant, T is the absolute temperature, h is
the viscosity, andD is the diffusion coefficient. All datawere obtained by
the instrumental software.
Ex vivo IOP measurement
Fresh (harvested within 24 hours) porcine eyes (Sierra for Medical Sci-
ence) weremounted into a Styrofoam fixture and immobilizedwith dis-
section pins. Partial core vitrectomies were performed on each eye using
the Constellation Vision System vitrectomy console (Alcon Inc.), and11 of 14
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IOP was measured by a digital pressure sensor inserted in the vitreous
cavity (posterior segment of the eye) (Fig. 3A). A single 3-mm linear
incision was created in the sclera, about 3-mm distance radial from
the limbus, with the incision path running tangential to the limbus
perimeter. An infusion cannula was placed in the vitreous cavity on the
opposite side from the incision to supply a saline solution of about 37°C.
Saline solution was infused either from a gravity-fed saline drip bag or
from a digitally actuated infusion system. Partial core vitrectomy allowed
faster diffusion of the liquid through the vitreous cavity, and saline ejec-
tion from the incision site confirmed incision success. Once confirmed,
the infusion line was clamped to limit leakage during the test. The eye
surface was dried with swabs to enable clean placement of the test sub-
stance (Fig. 3A). After this process, the IOP was gradually raised from
baseline by manually increasing the infusion pump pressure until leak-
age was observed or the pressure sensor value no longer increased with
increasing infusion rate (indicative of a nonvisible leak). Themaximum
pressure held (in millimeters of mercury) was recorded.
In vitro adhesion test
We prepared a range of 0.8 to 43% (w/w) PNIPAM and 30% (w/w)
N95BA5 hydrogels for uniaxial adhesion testing. Fresh (harvestedwithin
24 hours) porcine eyes (Sierra forMedical Science) were dissected into a
2-cm × 2-cm square shape. Hydrogel was compressed between two
pieces of dissected scleral tissue fixated to the base and actuator arm
of the pull tester (Fig. 3F). Apposed tissues were put into contact and
pressed together using 15g of pressure for 2min. The actuator then per-
formed a pulling motion until the two samples separated, compromis-
ing the gel adhesion.
Deployment tool development and use
To deploy the hydrogel in the eye, a novel tool was developed as follows:
an 18-gauge intravenous catheter tip trimmed to 5 to 8 mm was at-
tached onto the Luer-Lock end of the 1-cm3 syringe, whichwas inserted
through the opening of the 15-cm3 syringe. The space between the ex-
ternal wall of the 1-cm3 syringe and the internal wall of the 15-cm3 sy-
ringe was filled with ammonium nitrate and water. The endothermic
dissolution reaction for the cooling mechanism was calibrated by using
a pair of digital thermocouples to track the temperature in the jacketing
chamber and inside the hydrogel chamber when different quantities of
water and ammonium nitrate were mixed together. A working range of
about 7 to 15 ml of water mixed with 6 to 8 g of ammonium nitrate
would result in a temperature-lowering profilemeeting the performance
criteria. For testing and use, the tool components were first sterilized,
and then, a sterile 1-cm3 syringe loaded with hydrogel was loaded into
the jacket. The jacket was loaded with ammonium nitrate and capped
with a rubber vial cap.When ready for use, a separate syringe filled with
sterile water and capped with an 18-gauge needle was inserted through
the rubber vial cap, and water was injected into the jacket chamber. The
tool was shaken a few times vigorously to initiate the reaction. After 60 s,
the gel was ready for application.
Hydrogel preparation for in vivo validation
The 30% N95BA5 hydrogel used for in vivo characterization was steri-
lized by firstmeasuring a prescribed quantity (1.0 g) of the dried powder
form into a 10-cm3 glass crimp vial container. Each open and filled con-
tainer was placed inside a Tyvek sterilization pouch with the associated
stopper and crimp top. The pouch was then sealed and ethylene oxide–
sterilized. Still inside the sealed and sterilized pouch, the stopper and
crimp top weremanipulated on top of the open container, and the con-Bayat et al., Sci. Transl. Med. 9, eaan3879 (2017) 6 December 2017tainer was crimped shut inside the pouch. Once sealed, the pouch was
opened, and the jar was withdrawn, leaving a sealed crimp container
with 0.5 g of sterile hydrogel powder. The sterilized hydrogel powders
were hydrated by injecting sterile water into the vial and performing the
hydrationprocedure described previously.Oncehydrated, the containers
were transferred to a refrigerator for storage until use.
In vivo study design
An unblinded, two-arm randomized (2:1, treatment/control) study was
conducted, in which all animals received 3-mm full-thickness incisions
in the sclera of the right eye (OS) about 3mmposterior to the limbus in
the temporal superior quadrant tomimic a traumatic injury. The fellow
eye (OD) in all rabbits was left untouched as a control. Treatment group
animals received the hydrogel intervention. Control group animals re-
ceivedno intervention (current standardof care). PigmentedNewZealand
rabbits were used for this study because the eye dimensions closely
approximate the size of the human eye, thus mimicking approximate
conditions for human use of the system.
For treatment group rabbits, once the open globe injury was created,
the hydrogel-loaded syringe was prepared for use, as described previ-
ously. About 0.1 to 0.3 cm3 of hydrogel was used for each procedure.
Control group rabbits received the same surgical procedure to the right
eye but received no intervention. At the end of each procedure, all
rabbits in both groups received (quantity) subcutaneous injections of
buprenorphine with repeat injections at 12-hour intervals for 48 hours.
The research team regularly monitored each rabbit for the first 6 hours
after the procedure. They then performed checkups at 6-hour intervals
through the first 12hours, followedby12-hour interval checkups through
the first week. At each 12-hour follow-up, rabbits were removed from
their cage, and their eyes were visually inspected by the research team
for any evidence of adverse tissue responses, such as swelling, inflam-
mation, or bleeding from the sclera, conjunctiva, or other surrounding
tissues, with instructions to notify the ophthalmologists of the team of
any adverse events.
In vivo IOP measurements
IOP of both eyes of all animals was measured using a magnetically ac-
tuated veterinary rebound tonometer (Tonovet). Baseline IOP values
were established by measuring IOP of each eye twice daily (a.m. and
p.m.) for 5 days leading up to the procedure (Fig. 5D). The Tonovet cal-
culates an average reading from six tonometric measurements taken
in succession. Four successive readings were taken on each eye; thus,
24measures contributed to the averaged IOP for each eye. For all tonom-
etry measures, rabbits were removed from the cage and placed on an
evaluation table for 2 min to allow the animal to relax. Stress from
handling is known to artificially elevate blood pressure and IOP values.
The average of three IOP measurements was recorded at each time
point for each eye (both OS and OD) at regular intervals after the
surgical procedure. Normalized IOP values were reported by dividing
IOPOS by IOPOD to reduce the impact of confounding systemic effects
(stress, infection, and medications). All surgical procedures were per-
formed in the a.m. and completed before noon, thus allowing IOPmea-
sures to resume in the late p.m. of the same day.
In vivo study endpoint
Study endpoints for the rabbits were set at 48 hours, 1week, and 4weeks
to evaluate the progression of the tissue response at the implant site.
Rabbits were not followed longer than 4 weeks because the intended
use of the hydrogel will be for less than 30 days. Rabbits were euthanized12 of 14
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by first administering a heavy dose of ketamine/xylazine anesthesia,
followed by intravenous injection of a lethal dose of sodium pento-
barbital via the auricular vein. Once euthanized, a surgical procedure
was performed to quickly enucleate and fix the study eyes (OS).
In vivo histology analysis
Enucleated eyes were fixed in Davidson’s solution to preserve structure
of the total globe. Tissues were sectioned and stained with either hema-
toxylin and eosin (H&E) or Masson’s trichrome stain to evaluate local
inflammatory response and characterize fibrosis. Retinal detachments
were assessed by histological evaluation of the posterior segments at
study endpoints. Retinas were analyzed for evidence of photoreceptor
outer segment disorganization or complete degeneration, indicative of
retina separation from the choroidal vasculature and nutrient supply. In
addition to evaluation of the overall structure, tissues were sent to an
outside pathology laboratory (Comparative Bioscience Inc.) to be eval-
uated by a certified veterinary pathologist for evidence of cytotoxic or
neurotoxic effects of the hydrogel on surrounding tissues.
Statistical analysis
For each animal at each timepoint, a normalized IOPmeasurementwas
calculated as IOPOD/IOPOS (Fig. 5E). The normalized measurement
was statistically compared between treated and untreated groups using
a generalized estimating equations model to account for correlated data
arising from the repeated measures of IOP within an animal. The re-
peatedly measured normalized IOP was the dependent variable; inde-
pendent variables were treatment group and time (day, a.m./p.m.) of
measurement. The postsurgery treatment effect on IOP was tested over
all postsurgical assessments, as well as at each measurement time. An
omnibus test of treatment effect over postinjury time was tested by a
score test of themain effect of treatment. Time-specific treatment effects
were compared between groupswith the addition of a day-by-treatment
interaction term; treatment group differences were compared at each
time point with a Wald test looking for a statistically significant
difference between the two groups (a = 0.05; two-sided).Mean (Standard
Error of the Mean, SEM) outcome measurements were estimated and
plotted for each day and treatment group. Eighteen animals randomized
in a 2:1 fashion provided exceptional power (>95% for the treatment





Fig. S1. Schematic synthesis routes of the N85NT15 and N95BA5 copolymers.
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prevent further tissue damage or vision loss before surgery.
exposure to cold water. In combat or low-resource settings, this hydrogel could close wounds temporarily to 
pressure without evidence of chronic inflammation or toxicity. After gelation, the sealant could be removed by
easily deployed from a custom-designed temperature-controlled syringe device and preserved intraocular 
a temporary sealant. Testing the hydrogel in a model of open globe injury in rabbits showed that the sealant was
suturing or adhesives, Bayat and colleagues developed a temperature-responsive synthetic hydrogel that acts as 
Traumatic eye injuries require rapid treatment to prevent deterioration of vision. As an alternative to
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